"AZ Nikolaas (fusie AZ Waasland en AZ Maria Middelares) telt 810 bedden. Het ziekenhuis heeft 5 campussen in het Waasland: Sint-Niklaas, Temse, Hamme, Beveren en Sint-Gillis-Waas. In Lokeren heeft het ziekenhuis een aparte low care afdeling. Dagelijks kunnen we rekenen op de inzet van meer dan 2300 medewerkers waarvan ruim 230 artsen. Zij bieden op deskundige wijze specialistische gezondheidszorg en dringende medische hulpverlening aan gehospitaliseerde en ambulante patiënten."

During the past decade, AZ Nikolaas (Sint Niklaas) conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Nikolaas (Sint Niklaas)" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Amgen" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "AgNovos Healthcare, LLC" with 1 trials sponsored and "PDC*line Pharma SAS" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Nikolaas (Sint Niklaas)" #1 collaborator was "KCR S.A." with 1 trials as a collaborator and "genae Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "AZ Nikolaas (Sint Niklaas)" are "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Breast Cancer" (1 trials), "Chest Pain" (1 trials) and "KRAS p, G12c Mutated /Advanced Metastatic NSCLC" (1 trials). Many other conditions were trialed in "AZ Nikolaas (Sint Niklaas)" in a lesser frequency.

Most popular intervention types in "AZ Nikolaas (Sint Niklaas)" are "Drug" (8 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGN1 Femoral Local Osteo-Enhancement Procedure" (1 trials), "AMG 510" (1 trials), "Alimta Injectable Product" (1 trials), "Aspirin" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "AZ Nikolaas (Sint Niklaas)" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Nikolaas (Sint Niklaas)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in AZ Nikolaas (Sint Niklaas), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AZ Nikolaas (Sint Niklaas), 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".